Role of receptor heterodimers in the development of l-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease

Chiara Fiorentini, Chiara Busi, PierFranco Spano, Cristina Missale

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Chronic l-dopa administration is associated with development of dyskinesias. The molecular mechanisms of these side-effects, however, remain elusive. Dopamine (DA) receptors interact with other receptors to form highly organized complexes where their activity is finely tuned by several proteins. The DA D1R forms a heteromeric complex with the NMDA receptor (NMDAR) and this interaction influences the trafficking of both receptors. Using the 6-hydroxydopamine rat model of Parkinson's disease, we report a correlation between the development of l-dopa-induced dyskinesias and changes in synaptic D1R/NMDAR complexes.

Original languageEnglish
JournalParkinsonism and Related Disorders
Volume14
Issue numberSUPPL.2
DOIs
Publication statusPublished - Jul 2008

Fingerprint

Dihydroxyphenylalanine
Oxidopamine
Dyskinesias
N-Methyl-D-Aspartate Receptors
Parkinson Disease
Dopamine Receptors
Dopamine
Proteins

Keywords

  • D1 receptor
  • Desensitization
  • Dimerization
  • Dopamine
  • Glutamate
  • NMDA receptor

ASJC Scopus subject areas

  • Ageing
  • Clinical Neurology
  • Neurology

Cite this

Role of receptor heterodimers in the development of l-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease. / Fiorentini, Chiara; Busi, Chiara; Spano, PierFranco; Missale, Cristina.

In: Parkinsonism and Related Disorders, Vol. 14, No. SUPPL.2, 07.2008.

Research output: Contribution to journalArticle

@article{d3cabac96c4043688db07ab29699973c,
title = "Role of receptor heterodimers in the development of l-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease",
abstract = "Chronic l-dopa administration is associated with development of dyskinesias. The molecular mechanisms of these side-effects, however, remain elusive. Dopamine (DA) receptors interact with other receptors to form highly organized complexes where their activity is finely tuned by several proteins. The DA D1R forms a heteromeric complex with the NMDA receptor (NMDAR) and this interaction influences the trafficking of both receptors. Using the 6-hydroxydopamine rat model of Parkinson's disease, we report a correlation between the development of l-dopa-induced dyskinesias and changes in synaptic D1R/NMDAR complexes.",
keywords = "D1 receptor, Desensitization, Dimerization, Dopamine, Glutamate, NMDA receptor",
author = "Chiara Fiorentini and Chiara Busi and PierFranco Spano and Cristina Missale",
year = "2008",
month = "7",
doi = "10.1016/j.parkreldis.2008.04.022",
language = "English",
volume = "14",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",
number = "SUPPL.2",

}

TY - JOUR

T1 - Role of receptor heterodimers in the development of l-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease

AU - Fiorentini, Chiara

AU - Busi, Chiara

AU - Spano, PierFranco

AU - Missale, Cristina

PY - 2008/7

Y1 - 2008/7

N2 - Chronic l-dopa administration is associated with development of dyskinesias. The molecular mechanisms of these side-effects, however, remain elusive. Dopamine (DA) receptors interact with other receptors to form highly organized complexes where their activity is finely tuned by several proteins. The DA D1R forms a heteromeric complex with the NMDA receptor (NMDAR) and this interaction influences the trafficking of both receptors. Using the 6-hydroxydopamine rat model of Parkinson's disease, we report a correlation between the development of l-dopa-induced dyskinesias and changes in synaptic D1R/NMDAR complexes.

AB - Chronic l-dopa administration is associated with development of dyskinesias. The molecular mechanisms of these side-effects, however, remain elusive. Dopamine (DA) receptors interact with other receptors to form highly organized complexes where their activity is finely tuned by several proteins. The DA D1R forms a heteromeric complex with the NMDA receptor (NMDAR) and this interaction influences the trafficking of both receptors. Using the 6-hydroxydopamine rat model of Parkinson's disease, we report a correlation between the development of l-dopa-induced dyskinesias and changes in synaptic D1R/NMDAR complexes.

KW - D1 receptor

KW - Desensitization

KW - Dimerization

KW - Dopamine

KW - Glutamate

KW - NMDA receptor

UR - http://www.scopus.com/inward/record.url?scp=47049101484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47049101484&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2008.04.022

DO - 10.1016/j.parkreldis.2008.04.022

M3 - Article

VL - 14

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

IS - SUPPL.2

ER -